earnings
confidence high
sentiment positive
materiality 0.80
Repligen Q2 revenue $182M (+17% organic non-COVID); orders >20% YoY; raises FY guidance
REPLIGEN CORP
2025-Q2 EPS reported
$0.37
revenue$351,538,000
- Revenue $182M, up 15% reported and 17% organic non-COVID YoY.
- GAAP EPS $0.26 vs $0.10; adjusted EPS $0.37 vs $0.40.
- Orders grew >20% YoY and sequentially, 8th consecutive quarter of orders exceeding non-COVID revenue.
- Raises FY2025 revenue guidance to $715-$735M, organic non-COVID growth 12.5%-15.5%.
- All franchises grew YoY; consumables >20%, biopharma +20%, all geographies mid-teens.